|Peter M. DeComo, the Chairman and Chief Executive Officer founded and shepherded Renal Solutions to a $200 million acquisition by Fresenius Medical Care in late 2007. In addition, he is a registered respiratory therapist, and has an extensive background in extracorporeal therapies.|
|Rachel Allen, General Counsel has over 20 years of experience acting as the principal outside lawyer on numerous completed M&A, venture capital, and private equity transactions in a variety of industries, including health care, medical device, and energy.|
|Joseph Argyros, Senior Vice President – Operations has extensive experience in leading medical device product development, manufacturing and service operations. He has held senior positions in these capacities at Neuro Kinetics and Nomos.|
|David J. Haffner, Executive Vice President, CFO & COO, recently served as CFO of Foundation Radiology, ClearCount Medical Solutions and NOMOS Corporation, all venture backed medical device companies. He is a CPA and received a BS degree in Accounting and Management Information Systems from the Pennsylvania State University.|
|Jeremy D. Kimmel, PhD, Vice President of New Technology has extensive experience in research and development of blood purification devices for the critically ill. Prior to ALung, Dr. Kimmel developed advanced medical technologies at the University of Pittsburgh and Pall Corporation.|
|Frank J. Falcione, Senior Vice President – Regulatory Affairs and Quality Assurance has extensive experience in FDA submissions and ISO quality system implementation. He has held senior positions in these capacities at CHS Business Associates, Emerson and Chiron Diagnostics.|
|Laura W. Lund, PhD, Vice President – Clinical Science has extensive experience in the research, design, and validation of blood gas exchange technology. Prior to ALung, Dr. Lund was an assistant professor in the Department of Bioengineering at the University of Pittsburgh’s Swanson School of Engineering.|
|Scott Morley, Senior Vice President of Market Development has an extensive background in biomedical engineering, clinical affairs, and marketing having held senior positions in these roles at ALung. He has been with the Company since 2003.|
William Federspiel, PhD, Head of the Scientific Advisory Board and co-founder, is the Director of the Medical Devices Laboratory, McGowan Institute for Regenerative Medicine, University of Pittsburgh where he is a William Kepler Whiteford Professor of Bioengineering, Chemical Engineering, and Critical Care Medicine.
Board of Directors
Jeanne Cunicelli, a board member, is an Executive Vice President of UPMC Enterprises. Ms. Cunicelli has more than two decades of investment and advising experience in the life sciences industry.
Peter M. DeComo, the Chairman and Chief Executive Officer founded and shepherded Renal Solutions to a $200 million acquisition by Fresenius Medical Care in late 2007. In addition, he is a registered respiratory therapist, and has an extensive background in extracorporeal therapies.
Gary G. Glausser, a board member, is the Chief Investment Officer of Innovation Works (IW). Gary oversees IW’s investment fund(s), chairs its Investment Committee and helps IW source, evaluate and invest in the region’s most promising startups. He is also General Partner at Birchmere Ventures, a fully invested venture capital fund with $160 million under management. Mr. Glausser has over 30 years experience in financial management, investing, lending, and public accounting.
Gerald E. McGinnis, a board member, is the founder and former Chairman of Respironics, a company he sold to Philips Medical for $5.1 billion in 2008. He has career-long experience in pulmonary products, both in home and hospital care.
John McIlwraith, a board member, is a Managing Director at Allos Ventures, an early-stage venture capital firm.
Kraig McEwen, a board member, is Executive Chairman of TrellisRx. Previously he was the CEO of Aesynt Inc., formerly McKesson Automation, Inc. (MAI). Prior to Aesynt, Mr. McEwen was President and CEO of CardiacAssist and Senior Vice President of Medrad Inc.
Dr. Adam Seiver, MD, PhD, a board member, is Chief Medical Officer of Philips Patient Care and Monitoring Systems. Prior to joining industry—Respironics in 2003, and then Philips via acquisition in 2008—he practiced trauma surgery and surgical intensive care for 20 years on the faculty of the Department of Surgery at Stanford Medical School, in Palo Alto, California. His current clinical practice involves critical care telemedicine, directing the 161-bed eICU program (VISICU/Philips) of the Sutter Health System, Sacramento, California.